Literature DB >> 29528162

Antibiotics resistance of Helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China.

Xiaoli Shu1, Guofeng Yin1,2, Mingnan Liu1, Kerong Peng3, Hong Zhao3, Mizu Jiang1,3.   

Abstract

BACKGROUND: The decreasing eradication rate of Helicobacter pylori is mainly because of the progressive increase in its resistance to antibiotics. Studies on antimicrobial susceptibility of H. pylori in children are limited. This study aimed to investigate the resistance rates and patterns of H. pylori strains isolated from children.
MATERIALS AND METHODS: Gastric mucosa biopsy samples obtained from children who had undergone upper gastrointestinal endoscopy were cultured for H. pylori, and susceptibility to six antibiotics (clarithromycin, amoxicillin, gentamicin, furazolidone, metronidazole, and levofloxacin) was tested from 2012-2014.
RESULTS: A total of 545 H. pylori strains were isolated from 1390 children recruited. The total resistance rates of H. pylori to clarithromycin, metronidazole, and levofloxacin were 20.6%, 68.8%, and 9.0%, respectively. No resistance to amoxicillin, gentamicin, and furazolidone was detected. 56.1% strains were single resistance, 19.6% were resistant to more than one antibiotic, 16.7% for double resistance, and 2.9% for triple resistance in 413 strains against any antibiotic. And the H. pylori resistance rate increased significantly from 2012-2014. There was no significant difference in the resistance rates to clarithromycin, metronidazole, and levofloxacin between different gender, age groups, and patients with peptic ulcer diseases or nonulcer diseases.
CONCLUSIONS: Antibiotic resistance was indicated in H. pylori strains isolated from children in Hangzhou, and it increased significantly during the 3 years. Our data strongly support current guidelines, which recommend antibiotic susceptibility tests prior to eradication therapy.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Helicobacter pylori (H. pylori); antibiotic resistance; children; clarithromycin; metronidazole

Mesh:

Substances:

Year:  2018        PMID: 29528162     DOI: 10.1111/hel.12481

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  7 in total

1.  Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.

Authors:  Xiaoli Shu; Diya Ye; Chenmin Hu; Kerong Peng; Hong Zhao; Huamei Li; Mizu Jiang
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

2.  Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China.

Authors:  Tian Geng; Zhong-Su Yu; Xi-Xi Zhou; Bo Liu; Hui-Hua Zhang; Zhong-Yue Li
Journal:  Eur J Pediatr       Date:  2022-04-25       Impact factor: 3.860

3.  Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia-findings from a molecular based study.

Authors:  Suat Moi Puah; Khean Lee Goh; Heng Kang Ng; Kek Heng Chua
Journal:  PeerJ       Date:  2021-06-09       Impact factor: 2.984

4.  Genetic and Transcriptomic Variations for Amoxicillin Resistance in Helicobacter pylori under Cryopreservation.

Authors:  Xiurui Han; Yiyao Zhang; Lihua He; Ruyue Fan; Lu Sun; Dongjie Fan; Yanan Gong; Xiaoli Chen; Yuanhai You; Fei Zhao; Maojun Zhang; Jianzhong Zhang
Journal:  Pathogens       Date:  2021-05-30

5.  Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication.

Authors:  Ya-Wen Zhang; Wei-Ling Hu; Yuan Cai; Wen-Fang Zheng; Qin Du; John J Kim; John Y Kao; Ning Dai; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2018-10-28       Impact factor: 5.742

6.  Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China.

Authors:  Yanyi Zhang; Yi Wen; Qiulin Xiao; Wei Zheng; Gao Long; Bo Chen; Xiaoli Shu; Mizu Jiang
Journal:  Infect Drug Resist       Date:  2020-01-30       Impact factor: 4.003

7.  Ninety-four thousand-case retrospective study on antibacterial drug resistance of Helicobacter pylori.

Authors:  Yu Zhang; Fei Meng; Jie Jin; Jun Wang; Bin-Bin Gu; Jin-Bang Peng; Li-Ping Ye
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.